Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON).

PubWeight™: 0.89‹?›

🔗 View Article (PMID 8018369)

Published in Acta Oncol on January 01, 1994

Authors

B Zackrisson1, L Franzén, R Henriksson, B Littbrand, M Stratford, M Dennis, A M Rojas, J Denekamp

Author Affiliations

1: Department of Oncology, University of Umeå, Sweden.

Articles by these authors

Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90

Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98

Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet (2009) 4.50

Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A (2000) 4.46

Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet (2013) 4.04

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med (1996) 2.96

Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer (1984) 2.55

Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project) BMJ (1992) 2.45

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol (2001) 2.39

Radiosensitizers of hypoxic cells in solid tumors. Cancer Treat Rev (1976) 2.33

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med (1995) 2.23

Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol (1994) 2.22

Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06

Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis. Lancet (1996) 2.03

Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke (1994) 2.00

Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke (1997) 1.94

Mood disorders in the year after first stroke. Br J Psychiatry (1991) 1.93

Analysis of clinical specimens by hybridisation with probe containing repetitive DNA from Plasmodium falciparum. A novel approach to malaria diagnosis. Lancet (1984) 1.92

Cell kinetics and radiation biology. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 1.91

Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89

Duodenal intraepithelial lymphocyte-count revisited. Scand J Gastroenterol (2004) 1.88

Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87

Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Diet (2005) 1.81

Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. Radiat Res (1978) 1.80

Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol (1994) 1.77

Emotionalism after stroke. BMJ (1989) 1.76

Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol (1998) 1.74

Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry (2004) 1.72

Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J Clin Oncol (2000) 1.68

Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiat Res (1974) 1.66

Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer (1982) 1.65

Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. Eur J Cancer (1992) 1.64

Endothelial-cell proliferation in experimental tumours. Br J Cancer (1982) 1.63

Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62

The intelligence of hydrocephalic children. Arch Neurol (1981) 1.60

Hospital services for patients with acute stroke in the United Kingdom: the Stroke Association Survey of consultant opinion. Age Ageing (1995) 1.59

EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys (1995) 1.59

EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol (1995) 1.58

Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma. Radiat Res (1975) 1.57

Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys (2000) 1.55

Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet (1979) 1.55

A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol (1996) 1.54

Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry (2006) 1.54

Poor reading comprehension despite fast word decoding in children with hydrocephalus. Brain Lang (2001) 1.53

Systematic review of prognostic models in patients with acute stroke. Cerebrovasc Dis (2001) 1.52

A reproducible animal model of acute bleeding ulcer-the "ulcer maker". Gastroenterology (1976) 1.52

Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. AIDS Res Hum Retroviruses (1997) 1.48

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol (1998) 1.47

Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig Dis Sci (1998) 1.46

Outcome of deliberate self-poisoning. An examination of risk factors for repetition. Br J Psychiatry (1994) 1.45

The war against error: a 15 year experience of completion angioscopy following carotid endarterectomy. Eur J Vasc Endovasc Surg (2011) 1.45

Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains. Biochemistry (1987) 1.45

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Br J Cancer (1988) 1.44

The cellular proliferation kinetics of animal tumors. Cancer Res (1970) 1.42

Vascular occlusion and tumour cell death. Eur J Cancer Clin Oncol (1983) 1.42

Lack of correspondence between the amplitudes of spontaneous potentials and unit potentials evoked by nerve impulses at regenerating neuromuscular junctions. Nat New Biol (1971) 1.41

The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med (1996) 1.39

Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased? Stroke (1997) 1.38

Entering the third millennium after a century of ionizing radiation in science and oncology. Acta Oncol (1999) 1.38

Time- and dose-related changes in the expression of substance P in salivary glands in response to fractionated irradiation. Int J Radiat Oncol Biol Phys (1995) 1.38

The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours. Eur J Cancer (1972) 1.37

In vitro and in vivo labelling of animal tumours with tritiated thymidine. Cell Tissue Kinet (1973) 1.36

Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest (1990) 1.36

Activity of the plasma membrane H(+)-ATPase and optimal glycolytic flux are required for rapid adaptation and growth of Saccharomyces cerevisiae in the presence of the weak-acid preservative sorbic acid. Appl Environ Microbiol (1996) 1.35

Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ (1997) 1.34

Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke (1998) 1.34

Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses (1993) 1.34

The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. Cancer Res (1985) 1.33

Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun (2001) 1.33

The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry (1990) 1.31

Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer (1999) 1.30

The effects of knowledge availability and knowledge accessibility on coherence and elaborative inferencing in children from six to fifteen years of age. J Exp Child Psychol (1996) 1.29

Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. J Biol Chem (1992) 1.27

Proliferation studies of the endothelial and smooth muscle cells of the mouse mesentery after irradiation. Cell Tissue Kinet (1980) 1.27

Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas. Cell Tissue Kinet (1982) 1.27

Self-poisoning patients discharged from accident and emergency: risk factors and outcome. J R Coll Physicians Lond (1991) 1.26

LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int J Gynecol Cancer (2007) 1.26

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci (2011) 1.25

Mathematical basis of point-area deconvolution method for determining in vivo input functions. J Pharm Sci (1978) 1.25

A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease. Aliment Pharmacol Ther (2007) 1.24

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis. Br J Cancer (2003) 1.24

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study. Br J Cancer (2003) 1.22

Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol (1973) 1.21

Highly reiterated non-coding sequence in the genome of Plasmodium falciparum is composed of 21 base-pair tandem repeats. J Mol Biol (1985) 1.21

Vascular endothelium as the vulnerable element in tumours. Acta Radiol Oncol (1984) 1.20

Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol (1994) 1.20

A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys (1985) 1.18

Late radiation damage in the mouse bladder as measured by increased urination frequency. Radiat Res (1978) 1.18

Weak-acid preservatives: modelling microbial inhibition and response. J Appl Microbiol (1999) 1.18

The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582. Radiat Res (1976) 1.17

Vinca alkaloids: anti-vascular effects in a murine tumour. Eur J Cancer (1993) 1.17

Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys (1977) 1.16

How do scores on the EuroQol relate to scores on the SF-36 after stroke? Stroke (1999) 1.16

Diurnal variation in incidence of stroke: Oxfordshire community stroke project. BMJ (1992) 1.14